ArticleOncology letters2017

BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway.

Mao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.